This blog began in 2005. It was a Christmas present from my daughter. She named it 1boringoldman because on a former blog with two other friends that was supposed to be news about our retirements, the only person writing was me, and I could only talk about one thing – the Invasion of Iraq. A […]
Kraepelin [1856-1926] Jaspers [1883-1969] Freud [1856-1939] If you know of Karl Jaspers, you were probably one of those philosophy majors who read his commentaries on Kierkegaard and Nietzsche, knowing him as an important mid-20th century German philosopher. But he was, in fact, a psychiatrist who wrote a classic psychiatric text in 1913 at age thirty, […]
[One of the many helpful things Ed Silverman does on is publish Pharmalot op-eds from the people in the know. This one is about the Roche·Tamiflu·Cochrane Collaboration controversy]. Trial Data Down The Rabbit Hole: Heneghan Explains Pharmalot By Ed Silverman March 4th, 2013 Last week, Roche responded to criticism over its handling of Tamiflu clinical […]
[link] New opportunities for treatment development. The enormous expansion of the medication portfolio for mental disorders between 1980 and 2000 was limited to a relatively narrow space of biology. Over the past decade, a new focus on the genetics and neurobiology of these disorders has generated a range of new targets for next-generation treatments. In […]
It has been a little over a year since Allen Jones and the State of Texas v. Johnson & Johnson et al [the TMAP Trial] in Austin Texas. I had by then spent a couple of years blogging about the corruption in the psychopharmacologic industry, and I flew out for the trial. Frankly, my reason […]
In closely reading many of the Clinical Trials of the psychoactive drugs in the last thirty years, I found that the majority put varying levels of spin on the data. I didn’t expect that. I had spent my medical life believing that the Journal editing process and peer review process was a system that wouldn’t […]
DSM-5 and the Sorry State of American Psychiatry Hooked by Howard Brodie February 28, 2013 If you think I’ve been underproducing blog posts lately, you can lay the blame at the doorstep of Rick Bukata and Jerry Hoffman of Primary Care Medical Abstracts. Being a lazy cuss, I often don’t know that an article of […]
Apparently, the good news reported from Roche about the Tamiflu Clinical Trial Data wasn’t such good news after all [good news…]. Roche says it will not relinquish control over access to clinical trial data British Medical Journal via Pharmagossip By Zosia Kmietowicz March 1, 2013 Campaigners for full transparency of all clinical trial data have […]